Center-Authored Papers

Filters: Author is Disis, Mary L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
V
Stanton SE, Adams S, Disis ML.  2016.  Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review.. JAMA oncology. Abstract
T
Cheever MA, Schlom J, Weiner LM, Lyerly KH, Disis ML, Greenwood A, Grad O, Nelson WG.  2008.  Translational Research Working Group developmental pathway for immune response modifiers.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(18):5692-9. Abstract
Paulson KG, Iyer JG, Tegeder AR, Thibodeau R, Schelter J, Koba S, Schrama D, Simonson WT, Lemos BD, Byrd DR et al..  2011.  Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(12):1539-46. Abstract
Weber JS, Yang JC, Atkins MB, Disis ML.  2015.  Toxicities of Immunotherapy for the Practitioner.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
Li ZY, Liu Y, Tuve S, Xun Y, Fan X, Min L, Feng Q, Kiviat N, Kiem H-P, Disis ML et al..  2009.  Toward a stem cell gene therapy for breast cancer.. Blood. 113(22):5423-33. Abstract
Salazar LG, Lu H, Reichow JL, Childs JS, Coveler AL, Higgins DM, Waisman J, Allison KH, Dang Y, Disis ML.  2017.  Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical Trial.. JAMA oncology. Abstract
Liao JB, Disis ML.  2013.  Therapeutic vaccines for ovarian cancer.. Gynecologic oncology. Abstract
Disis ML.  2016.  Thank You JAMA Oncology Authors, Peer Reviewers, and Readers.. JAMA oncology.
Disis ML, Watt WC, Cecil DL.  2014.  Th1 epitope selection for clinically effective cancer vaccines.. Oncoimmunology. 3(9):e954971. Abstract
Cecil DL, Park KH, Gad E, Childs JS, Higgins DM, Plymate SR, Disis ML.  2013.  T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity.. Breast cancer research and treatment. 139(3):657-65. Abstract
S
Pathangey LB, McCurry DB, Gendler SJ, Dominguez AL, Gorman JE, Pathangey G, Mihalik LA, Dang Y, Disis ML, Cohen PA.  2016.  Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.. Oncotarget. Abstract
Watt WC, Cecil DL, Disis ML.  2016.  Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer.. Seminars in immunopathology. Abstract
Amory JK, Louden DKN, McKinney C, Rich J, Long-Genovese S, Disis ML.  2017.  Scholarly productivity and professional advancement of junior researchers receiving KL2, K23, or K08 awards at a large public research institution.. Journal of clinical and translational science. 1(2):140-143. Abstract
P
Chao T, Ladd JJ, Qiu J, Johnson MM, Israel R, Chin A, Wang H, Prentice RL, Feng Z, Disis ML et al..  2013.  Proteomic profiling of the autoimmune response to breast cancer antigens uncovers a suppressive effect of hormone therapy.. Proteomics. Clinical applications. 7(5-6):327-336. Abstract
Yang Y, Inatsuka C, Gad E, Disis ML, Standish LJ, Pugh N, Pasco DS, Lu H.  2014.  Protein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation.. Innate immunity. 20(8):857-66. Abstract
Engel AL, Sun G-C, Gad E, Rastetter LR, Strobe K, Yang Y, Dang Y, Disis ML, Lu H.  2013.  Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant.. Immunobiology. Abstract
Liao JB, Ovenell KJ, Curtis EEM, Cecil DL, Koehnlein MR, Rastetter LR, Gad EA, Disis ML.  2015.  Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer.. Journal for immunotherapy of cancer. 3:16. Abstract
Spira A, Yurgelun MB, Alexandrov L, Rao A, Bejar R, Polyak K, Giannakis M, Shilatifard A, Finn OJ, Dhodapkar M et al..  2017.  Precancer Atlas to Drive Precision Prevention Trials.. Cancer research. 77(7):1510-1541. Abstract
Butterfield LH, Disis ML, Fox BA, Khleif SN, Marincola FM.  2015.  Preamble to the 2015 SITC immunotherapy biomarkers taskforce.. Journal for immunotherapy of cancer. 3:8. Abstract
Liao JB, Swensen RE, Ovenell KJ, Hitchcock-Bernhardt KM, Reichow JL, Apodaca MC, D'Amico L, Childs JS, Higgins DM, Buening BJ et al..  2017.  Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer.. Gynecologic oncology. Abstract
Chow LQM, Morishima C, Eaton KD, Baik CS, Goulart BH, Anderson LN, Manjarrez KL, Dietsch GN, Bryan JK, Hershberg RM et al..  2016.  Phase 1b Trial of the Toll-Like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
N
Patel A, Kaufman HL, Disis ML.  2017.  Next generation approaches for tumor vaccination.. Chinese clinical oncology. 6(2):19. Abstract
Gad E, Rastetter L, Slota M, Koehnlein M, Treuting PM, Dang Y, Stanton S, Disis ML.  2014.  Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models.. Breast cancer research and treatment. 148(3):501-10. Abstract
M
Disis ML, Gad E, Herendeen DR, Lai VP-, Park KH, Cecil DL, O'Meara MM, Treuting PM, Lubet RA.  2013.  A Multiantigen Vaccine Targeting Neu, IGFBP-2, and IGF-IR Prevents Tumor Progression in Mice with Preinvasive Breast Disease.. Cancer prevention research (Philadelphia, Pa.). 6(12):1273-82. Abstract
Mao J, Ladd J, Gad E, Rastetter L, Johnson MM, Marzbani E, Childs JS, Lu H, Dang Y, Broussard E et al..  2014.  Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer.. Journal of translational medicine. 12(1):121. Abstract